glp-1 employer coverage news october 2025 Debate Comes Down to a 'Prisoner's Dilemma,' Lilly SVP Says Rising Employer Costs for GLP-1

The Proglucagon to GLP-1 Conversion L-cells contain the gene GCG, which encodes proglucagonthe precursor molecule for GLP-1

GLP-1 medications are considered a highly effective weight loss drug, providing sustainable results for those struggling with obesity

The region benefits from strong GLP-1 penetration in the United States, where prescriptions exceeded 7% of all dispensed prescriptions by December 2025

The ongoing multidistrict litigation (MDL) against pharmaceutical giants Novo Nordisk and Eli Lilly concerning GLP-1 drugs, including Ozempic, Wegovy, Trulicity, and Mounjaro, continues to develop as plaintiffs claim these medications have caused serious gastrointestinal injuries

Data for GLP-1 analogs and ulcerative colitis There is reason to think GLP-1 analogs could be beneficial for inflammatory bowel disease (IBD) patients